Theranica’s Post

Depending on wound type and comorbidities, complex wounds differ in both etiology and treatment pathway. The diverse nature of complex wounds necessitates tailored, evidence-based treatment plans and avoiding one-size-fits-all approaches that are often expensive and unproven. At Woundtech, we understand the distinctive nature of complex wounds and what is required to heal them. Woundtech brings wound healing to the patient’s home at a lower cost than clinic-based providers. Our provider-driven model is based on tailored, evidence-based care that is grounded in data and science—not fads. Across 23 years, Woundtech clinicians have made over 1.5M wound-related patient visits, serving Medicare Advantage, Medicaid, Commercial, and SNP patients across 7 states. Click here to learn more! https://hubs.la/Q02f2tWG0 #woundcare #whyWoundtech #healthcare #providerdrivencare #experiencematters

I'm thrilled to share the results of our recent contingency management pilot program implemented with all of the West Virginia Medicaid MCOs and five treatment systems in the state. West Virginia has seen a 490% increase in methamphetamine overdose deaths over the past 5 years, and with no FDA approved medication available for Stimulant Use Disorder (StimUD) like there are for other substances, Contingency Management is the best-evidenced treatment option. After 6 months of treatment, the results have been overwhelmingly positive: - 65% of members completed the entirety of their 6-month program - 87% of all tests taken by patients were negative for non-prescribed substances - 10.3 self-guided therapy (CBT) modules completed per active member per month By rewarding Medicaid members for achieving health goals like medication adherence and abstinence from illicit stimulants, DynamiCare Health’s digital contingency management platform helped drive significantly better outcomes. Read the full case study through the link below for additional stats and details on how we partnered with West Virginia Medicaid leaders to confront the stimulant epidemic head on. This successful pilot opens the door to wider contingency management adoption for the Medicaid population nationally. #contingencymanagement #stimulantuse #StimUD #addictiontreatment #addictionrecovery #motivationalincentives #behavioralhealth #substanceusedisorder #sobriety #relapseprevention #harmreduction #medicationadherence #smokingcessation #opioidrecovery #alcoholrecovery #sobrietyrewards #wvmedicaud #telehealthcoaching #randomdrugtesting #cognitivebehavioraltherapy #digitaltherapeutics https://lnkd.in/gRxS9QmW

📢 Attention Michigan Health Providers: 2024 Medicaid Manual Updates! 📢 The January 2024 Medicaid Provider Manual brings crucial updates, including the clarification of inpatient rapid whole genome sequencing (rWGS) coverage. Ensure your clinic's compliance with these changes! Kona Medical Consulting is here to guide you through the updated regulations, helping you provide the best care to your patients with the latest information. Let's navigate these updates together! #MedicaidUpdates #rWGS #KonaConsulting

Unfortunately, dental plans typically limit coverage to around $2,000. For head and neck cancer survivors who have endured radiation therapy, dental treatments can far exceed these plan limits. Dental care is a long-term issue that significantly impacts survivors' overall health. To address this gap, it is crucial to implement more community screenings and advocate for Medicare to cover oral/mouth screenings comprehensively. We applaud Medicare for expanding coverage for certain dental procedures, and we encourage it to continue to do so. Effectively catching oral cancer at its early stages will not only improve patient outcomes but also lower long-term medical costs associated with treating this terrible disease. MOPSS is actively advocating for insurers in Massachusetts to cover medically related dental treatments, and we hope that all states will follow suit in ensuring adequate care for cancer survivors.

Men's Health Month is all about raising awareness and promoting healthy habits for men’s physical, mental and emotional health. Men in the United States die an average of 5 years earlier than women and are at higher risk for many serious diseases, including heart disease, lung cancer and prostate cancer. Although all men are at risk for prostate cancer, Black men are at higher risk. They are twice as likely to get and die from prostate cancer than white men. Telligen is proud to offer our own suite of health equity solutions to identify and eliminate healthcare disparities to improve health for all. Learn more at Telligen.com/health-equity.

New findings alert: A 2024 report on patient access sheds light on hurdles that those living with chronic disease face, including insurance barriers and soaring medication costs. Shockingly, women endure longer diagnostic delays and higher financial strain than men. Despite the challenges highlighted in this report, there are steps we can take to improve outcomes. By raising awareness about women's disparities in diagnosis and care, we can work towards a future of equitable healthcare for all. Read the full report now. #HealthEquity #PatientAccess #DiabetesCare #ChronicCare #Podimetrics

I asked Dan Serrano to offer up his advice in the context of CKD (chronic kidney disease) patients. Why did I ask Dan to use the CKD case study, as a touchstone? Well, first of all, talking about this topic in totally theoretical terms is not ideal. We need an actual example for a lot of this to kind of make sense, combined with the first step for most outcomes improvement programs, which is to study your data and pick a patient population to focus on where the data suggests that you can have a big impact. And speaking of impact, did you know that an underlying reason why heart failure patients get hospitalized and rehospitalized is because of underlying CKD? So, impact in the short term and longer term, which I’ll get to in a sec. Another reason is—and I’m quoting John Rodis, MD, MBA, here, who is the independent medical director of QC-Health®—Dr. Rodis said the other day, “I sure as heck hope I don’t get CKD, because if I do, chances are I’m not going to be diagnosed. And even if I am diagnosed, I won’t be treated properly.” But also, here’s another reason I asked Dan Serrano to talk about CKD patient populations specifically as his example: I and Dr. Rodis and the team at QC-Health are not the only ones who have figured out that CKD patients are notoriously expensive and way underdiagnosed. You know who else has figured this out? Payers. Also, private equity. In fact, I was in a meeting with a payer recently, and they stated they had to get CKD patients into point solutions. Also mentioned in this #podcast: Daniel Serrano #payer #provider Eric Gallagher Vivek Garg, MD, MBA Amy Scanlan #ckd #chronickidneydisease John Rodis, MD #ESRD #kidneydisease #patients QC-Health®, Inc. #PCPs #FFS Laurence Bauer Scott Conard, MD jodilyn owen #clinicians #patientoutcomes Groundswell Movement Keith Passwater Society of Actuaries COPE Health Solutions Click to read the full article on the RHV Web site and listen to the #healthcarepodcast with Stacey Richter: https://cc-lnk.com/EP410

340B enables eligible entities to use savings to reach more eligible patients and provide more comprehensive services. That entails a full range of care and support that goes well beyond just providing discounted drugs to patients. Maureen Testoni's recent op-ed in RealClearHealth discusses this: bit.ly/4a01l1Y Safety-net hospitals provide critical services to underserved populations, providing 77% of hospital care for Americans with Medicaid and 67% of uncompensated and unreimbursed hospital care. Research shows #340B hospitals lead in providing safety-net benefits, supporting care for low-income & rural communities, and constraining drug price increases.

I asked Dan Serrano to offer up his advice in the context of CKD (chronic kidney disease) patients. Why did I ask Dan to use the CKD case study, as a touchstone? Well, first of all, talking about this topic in totally theoretical terms is not ideal. We need an actual example for a lot of this to kind of make sense, combined with the first step for most outcomes improvement programs, which is to study your data and pick a patient population to focus on where the data suggests that you can have a big impact. And speaking of impact, did you know that an underlying reason why heart failure patients get hospitalized and rehospitalized is because of underlying CKD? So, impact in the short term and longer term, which I’ll get to in a sec. Another reason is—and I’m quoting John Rodis, MD, MBA, here, who is the independent medical director of QC-Health®, Inc.®—Dr. Rodis said the other day, “I sure as heck hope I don’t get CKD, because if I do, chances are I’m not going to be diagnosed. And even if I am diagnosed, I won’t be treated properly.” But also, here’s another reason I asked Daniel Serrano to talk about CKD patient populations specifically as his example: I and Dr. Rodis and the team at QC-Health are not the only ones who have figured out that CKD patients are notoriously expensive and way underdiagnosed. You know who else has figured this out? Payers. Also, private equity. In fact, I was in a meeting with a payer recently, and they stated they had to get CKD patients into point solutions. Also mentioned in this #podcast: Daniel Serrano #payer #provider Eric Gallagher Vivek Garg, MD, MBA Amy Scanlan #ckd #chronickidneydisease John Rodis, MD #ESRD #kidneydisease #patients QC-Health®, Inc. #PCPs #FFS Laurence Bauer Scott Conard, MD jodilyn owen #clinicians #patientoutcomes Groundswell Movement Keith Passwater Society of Actuaries COPE Health Solutions Click to read the full article on the RHV Web site and listen to the Relentless Health Value Podcast: https://cc-lnk.com/EP410

I asked Dan Serrano to offer up his advice in the context of CKD (chronic kidney disease) patients. Why did I ask Dan to use the CKD case study, as a touchstone? Well, first of all, talking about this topic in totally theoretical terms is not ideal. We need an actual example for a lot of this to kind of make sense, combined with the first step for most outcomes improvement programs, which is to study your data and pick a patient population to focus on where the data suggests that you can have a big impact. And speaking of impact, did you know that an underlying reason why heart failure patients get hospitalized and rehospitalized is because of underlying CKD? So, impact in the short term and longer term, which I’ll get to in a sec. Another reason is—and I’m quoting John Rodis, MD, MBA, here, who is the independent medical director of QC-Health®—Dr. Rodis said the other day, “I sure as heck hope I don’t get CKD, because if I do, chances are I’m not going to be diagnosed. And even if I am diagnosed, I won’t be treated properly.” But also, here’s another reason I asked Dan Serrano to talk about CKD patient populations specifically as his example: I and Dr. Rodis and the team at QC-Health are not the only ones who have figured out that CKD patients are notoriously expensive and way underdiagnosed. You know who else has figured this out? Payers. Also, private equity. In fact, I was in a meeting with a payer recently, and they stated they had to get CKD patients into point solutions. Also mentioned in this #podcast: Daniel Serrano #payer #provider Eric Gallagher Vivek Garg, MD, MBA Amy Scanlan #ckd #chronickidneydisease John Rodis, MD #ESRD #kidneydisease #patients QC-Health®, Inc. #PCPs #FFS Laurence Bauer Scott Conard, MD jodilyn owen #clinicians #patientoutcomes Groundswell Movement Keith Passwater Society of Actuaries COPE Health Solutions Click to read the full article on the RHV Web site and listen to the #healthcarepodcast with Stacey Richter: https://cc-lnk.com/EP410